ArticleInternational journal of biological macromolecules2026
Evaluation of methemoglobin and polymerized methemoglobin for detoxification of cyanide, azide, and sulfide in in vitro binding models.
Article in International journal of biological macromolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of the Methemoglobin-Haptoglobin Protein Complex for Detoxification of Cyanide, Azide, and Sulfide in In Vitro Binding Models.Chemical research in toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cyanide, azide, and sulfide are fast-acting cellular poisons that inhibit mitochondrial respiration by targeting metal centers within key enzymes, leading to rapid energy failure and potentially lethal metabolic collapse. Despite their clinical relevance, specific antidotes capable of broadly neutralizing these toxic anions remain limited. Methemoglobin (methHb), the ferric form of hemoglobin with high affinity for these ligands, has been recognized as a mechanistic antidote capable of sequestering toxic anions before they reach mitochondrial targets. Polymerized hemoglobin (PolyhHb) and its oxidized counterpart, polymerized methemoglobin (metPolyhHb), offer a promising strategy to potentially enhance the stability, circulation time, and safety profile of methHb-based detoxification systems. In this study, we characterize methHb and metPolyhHb as multi-ligand scavengers using in vitro binding models. High-performance liquid chromatography (HPLC) and dynamic light scattering (DLS) demonstrated that oxidation of PolyhHb does not alter its molecular size or distribution. Circular dichroism confirmed preservation of secondary structure following oxidation. Using UV-visible spectroscopy and stopped-flow kinetics, we show that both methHb and metPolyhHb rapidly and efficiently bind cyanide, azide, and sulfide. These findings demonstrate that PolyhHb retains structural integrity upon oxidation and maintains strong detoxification capability across multiple toxic anions, supporting its potential as a versatile platform for broad-spectrum antidotal development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.